PAROLARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 12.270
EU - Europa 7.659
AS - Asia 1.456
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 7
AF - Africa 4
Totale 21.428
Nazione #
US - Stati Uniti d'America 12.231
IT - Italia 4.038
UA - Ucraina 1.450
SE - Svezia 760
TR - Turchia 613
VN - Vietnam 421
CN - Cina 377
IE - Irlanda 355
FI - Finlandia 352
DE - Germania 294
GB - Regno Unito 213
FR - Francia 100
CA - Canada 36
BE - Belgio 30
IN - India 16
EU - Europa 15
NL - Olanda 12
ES - Italia 7
BG - Bulgaria 6
BR - Brasile 6
RU - Federazione Russa 6
AU - Australia 5
CL - Cile 5
DK - Danimarca 5
PT - Portogallo 5
CH - Svizzera 4
JP - Giappone 4
PK - Pakistan 4
CO - Colombia 3
HK - Hong Kong 3
HU - Ungheria 3
MY - Malesia 3
SG - Singapore 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
GR - Grecia 2
IL - Israele 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
MX - Messico 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RO - Romania 2
AL - Albania 1
AT - Austria 1
BT - Bhutan 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 21.428
Città #
Milan 2.842
Fairfield 1.834
Woodbridge 1.128
Jacksonville 1.099
Chandler 1.089
Ashburn 977
Houston 828
Seattle 793
Wilmington 728
Ann Arbor 659
Cambridge 607
Dearborn 393
Princeton 380
Dublin 354
Izmir 352
Nyköping 349
Rome 230
Dong Ket 218
Como 190
San Mateo 161
New York 100
San Diego 88
Beijing 69
Ogden 61
Washington 59
Hefei 48
Kunming 42
Norwalk 38
Nanjing 34
London 33
Brussels 30
Toronto 27
Los Angeles 26
Ponte Lambro 23
Boardman 21
Nanchang 19
Verona 19
Guangzhou 18
Mcallen 18
Redwood City 18
Kocaeli 17
Berlin 16
Düsseldorf 16
Fuzhou 14
Falls Church 13
Jinan 13
Carbonara Al Ticino 12
Chicago 12
Edinburgh 12
Cagliari 10
Frankfurt am Main 9
Helsinki 9
Ottawa 8
Redmond 8
Shenyang 8
Varese 8
Benevento 7
Bologna 7
Chengdu 7
Kilburn 7
Wuhan 7
Amritsar 6
Ankara 6
Istanbul 6
Pune 6
Sofia 6
Zhengzhou 6
Auburn Hills 5
Chongqing 5
Lisbon 5
Naples 5
Phoenix 5
Siena 5
Wandsworth 5
Amsterdam 4
Bollate 4
Cairate 4
Chiswick 4
Copenhagen 4
Hebei 4
Hounslow 4
Islamabad 4
Madrid 4
Napoli 4
Prescot 4
San Giuliano Milanese 4
Shanghai 4
Stuttgart 4
Villanovafranca 4
Budapest 3
Changsha 3
Indiana 3
Jinhua 3
Kuala Lumpur 3
Manchester 3
Melbourne 3
Miami 3
Moscow 3
Paris 3
Salerno 3
Totale 16.386
Nome #
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 240
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 218
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 212
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 198
Assay of GTPγS binding in autoradiography 192
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 191
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 190
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 188
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 188
Long lasting consequences of cannabis exposure in adolescence. 186
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 185
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 184
New vistas on cannabis use disorder 184
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 183
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 183
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 180
A molecular basis of analgesic tolerance to cannabinoids 179
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 179
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 175
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 175
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 172
Cannabinoids and opioids share cAMP pathway in rat splenocytes 167
Endocannabinoids and Mental Disorders. 166
MeCP2 related studies benefit from the use of CD1 as genetic background 166
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 160
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat 156
Role of endocannabinoids in regulating drug dependence 156
Expression and function of the endocannabinoid system in glial cells. 153
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 153
Cannabinoids and Drugs of abuse 153
The endocannabinoid system and schizophrenia: integration of evidence. 152
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 151
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 150
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 150
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT? 150
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 149
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 147
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche 147
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 146
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 146
Sex-dependent vulnerability to cannabis abuse in adolescence 146
Molecular and cellular basis of cannabinoid and opioid interactions 145
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 144
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 142
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi 141
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor. 139
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 137
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 137
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 137
Endocannabinoids and Drug Dependence 137
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 135
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 134
Endocannabinoids in the immune system and cancer 133
The psychoactive ingredient of marijuana induces behavioural sensitization 132
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 132
null 132
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 131
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 131
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw 131
Cannabidiol inhibits angiogenesis by multiple mechanisms 131
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat 130
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 130
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system 129
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 128
The endocannabinoid system and psychiatric disorders. 128
Binding studies of dermorphin and its L-form on rat brain opioid receptors. 127
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 125
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 125
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects 125
Presence and functional regulation of cannabinoid receptors in immune cells 124
Cholera toxin effects on body temperature changes induced by morphine. 124
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats. 124
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 123
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 122
Pertussis toxin inhibits the antinociceptive action of morphine in the rat.. 121
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 120
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 119
A role of nitric oxide in WIN 55,212-2 tolerance in mice. 119
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors 118
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. 118
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 118
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. 118
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 118
Cannabinoids as potential new therapy for the treatment of gliomas. 117
Presence of a reduced opioid response in interleukin-6 knock out mice 117
Cannabinoids, immune system and cytokine network 117
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat. 117
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine.. 115
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells 114
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 114
Neurobiological mechanisms underlying cannabis-induced memory impairment 114
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system 112
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models 112
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system 112
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine. 111
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study. 111
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 109
Influence of pertussis toxin on thermic responses to morphine and neurotensin in rats.. 109
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. 108
Is cannabinoid transmission involved in rewarding properties of drugs of abuse 106
Totale 14.375
Categoria #
all - tutte 63.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.370 0 0 0 0 0 0 0 0 0 0 561 809
2019/20204.773 223 181 215 994 331 536 665 586 362 326 79 275
2020/20213.189 80 340 132 300 192 343 143 248 470 168 295 478
2021/20221.930 192 203 182 251 58 89 71 94 94 282 149 265
2022/20232.722 265 165 192 326 157 582 10 378 399 75 120 53
2023/20244.527 717 743 725 832 902 350 31 76 100 28 23 0
Totale 21.557